| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.916 | 1.893 | 2.825 | 2.445 | 2.918 | 2.166 | 2.757 | 2.909 | 3.747 | 2.716 |
| Total Income - EUR | 2.916 | 1.893 | 2.909 | 2.445 | 2.918 | 2.166 | 2.757 | 2.909 | 3.747 | 2.716 |
| Total Expenses - EUR | 2.657 | 3.608 | 2.829 | 2.712 | 2.539 | 4.242 | 2.048 | 4.142 | 2.265 | 1.700 |
| Gross Profit/Loss - EUR | 259 | -1.715 | 80 | -267 | 380 | -2.076 | 709 | -1.232 | 1.482 | 1.015 |
| Net Profit/Loss - EUR | 171 | -1.772 | -7 | -340 | 292 | -2.137 | 626 | -1.319 | 1.245 | 853 |
| Employees | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Manxmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.193 | 1.578 | 1.604 | 1.337 | 981 | 1.511 | 2.257 | 932 | 795 | 1.756 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.128 | 1.109 | 1.076 | 912 | 894 | 1.084 | 1.114 | 6 | 6 | 188 |
| Cash | 66 | 469 | 529 | 425 | 87 | 427 | 1.143 | 926 | 788 | 1.568 |
| Shareholders Funds | 1.886 | 95 | 86 | -255 | 42 | -2.096 | -1.423 | -2.747 | -1.493 | -632 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 308 | 1.483 | 1.518 | 1.592 | 940 | 3.607 | 3.736 | 3.743 | 2.345 | 2.388 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Manxmed S.r.l.